Behcet's disease associated with malignancy: A report of 41 Chinese cases

International Journal of Rheumatic Diseases

Volumn 17, Issue 4, 2014, Pages 459-465

  Lin, Yi ^a   Li, Guohua ^b   Zheng, Wenjie ^a   Tian, Xinping ^a   Zhang, Fengchun ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b Department of Nephrology   (China)

Author keywords

Behcet' s disease; Hematologic malignancy; Malignant solid neoplasm

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THALIDOMIDE; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADENOCARCINOMA; ADULT; APHTHOUS ULCER; ARTICLE; BEHCET DISEASE; BREAST CANCER; CANCER OF UNKNOWN PRIMARY SITE; CHINESE; CHRONIC LYMPHATIC LEUKEMIA; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE DURATION; ESOPHAGUS CANCER; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; KIDNEY CARCINOMA; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL SCHOOL; MYELODYSPLASTIC SYNDROME; NEOPLASM; PANCREAS CANCER; PRIORITY JOURNAL; STOMACH CANCER; THYROID CANCER; TRANSITIONAL CELL CARCINOMA; UTERINE CERVIX CANCER; ADOLESCENT; AGED; BEHCET SYNDROME; CHINA; COLORECTAL NEOPLASMS; COMPLICATION; HEMATOLOGIC NEOPLASMS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BEHCET SYNDROME; CHINA; COLORECTAL NEOPLASMS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84901279238     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12269     Document Type: Article

References (29)

1. Cenzig M, Altundag MK, Zorlu AF et al. (2001) Malignancy in Behcet'sdisease: a report of 13 cases and a review of the literature. Clin Rheumatol 20, 239-44.
2. Kural-Seyahi E, Fresko I, Seyahi N et al. (2003) The long-term mortality andmorbidity of Behcet syndrome: a 2-decade outcome survey of 387 patientsfollowed at a dedicated center. Medicine (Baltimore) 82 (1), 60-76.
3. Kaklamani VG, Tzonou A, Kaklamanis PG (2005) Behcet's disease associated with malignancies. Report of two cases and review of the literature. Clin Exp Rheumatol 23(4 Suppl 38), S35-41.
4. Ahn JK, Oh JM, Lee J et al. (2010) Behcet's disease associated with malignancy in Korea: a single center experience. Rheumatol Int 30, 831-5.
5. International Study Group for Behcet's Disease (1990) Criteria for diagnosis of Behcet's disease. Lancet 335, 1078-80.
6. Nishimura K, Fujiki R, Hirotsu J et al. (2004) A case of hilar bile duct cancer with intestinal Behcet's disease. Kurume Med J 51, 169-73.
7. Yamada M, Shiroeda H, Nomura T et al. (2011) Colon cancer arising in anulcer scar due to intestinal Behcet's disease. Intern Med 50, 429-32.
8. Nonami A, Takenaka K, Sumida C et al. (2007) Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behcet's disease by upfront cord blood transplantation. Intern Med 46, 1753-6.
9. Ono Y, Yamada M, Kawamura T et al. (2005) Central nervous system malignant lymphoma associated with Behcet's disease. Case report. Neurol Med Chir (Tokyo) 45 (11), 586-90.
10. Senel S, Kaya E, Aydogdu I et al. (2006) Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature. Rheumatol Int 26, 857-61.
11. Ozdogu H, Boga C, Yilmaz Z et al. (2007) Long-term colchicine therapy in a patient with Behcet's disease and acute promyelocytic leukemia. Rheumatol Int 27, 763-5.
12. Chen HC, Chiu YM (2012) Large-vessel thrombosis in intestinal Behcet's disease complicated with myelodysplastic syndrome and trisomy 8. World J Gastroenterol 18, 1137-40.
13. Meyer J, Wahidi M, Shofer S et al. (2008) Formation of a bronchoesophageal fistula following concurrent radiation and chemotherapy for lung cancer in the setting of Behcet's disease. J Thorac Oncol 3, 1361-2.
14. Chargari C, Kirova YM, Fourquet A et al. (2009) Severe acute radiationrelatedskin toxicity in a breast cancer patient with Behcet's disease. Radiother Oncol 91 (1), 139.
15. Mantzourani MG, Chantziara K, Thanopoulou I et al. (2009) Coexistence of Behcet's disease and chronic myelomonocyte leukemia with trisomy 8: a case report and review of the literature. Clin Exp Rheumatol 27 (2 Suppl 53), S85-7.
16. Souabni L, Elleuch M, Amira C et al. (2008) Malignant lymphoma of the tonsil in a patient with Behcet's disease. Joint Bone Spine 75, 616-8.
17. Chelly I, Limaiem F, Mekni A et al. (2008) Cutaneous gamma-delta T-cell lymphoma arising in the setting of Behcet's disease. Pathologica 100 (3), 166-9.
18. Saadoun D, Wechsler B, Desseaux K et al. (2010) Mortality in Behcet's disease. Arthritis Rheum 62, 2806-12.
19. Ferreyra Dillon R, Lascano CD, Riera F et al. (2011) Cutaneous cryptococosis in a patient with Behcet's disease and colon cancer. Reumatol Clin 7, 147-8.
20. Mezalek ZT, Harmouche H, Attar NE et al. (2007) Kaposi's sarcoma in association with Behcet's disease: case report and literature review. Semin Arthritis Rheum 36 (5), 328-31.
21. Bozi E, Katoulis AC, Stavrianeas NG (2007) Association of Behcet's disease with hematologic malignancies. Int J Dermatol 46, 333-4.
22. Tada Y, Koarada S, Haruta Y et al. (2006) The association of Behcet's disease with myelodysplastic syndrome in Japan: a review of the literature. Clin Exp Rheumatol 24 (5 Suppl 42), S115-9.
23. Ahn JK, Cha HS, Koh EM et al. (2008) Behcet's disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology 47, 1228-30.
24. Voulgarelis M, Giannouli S, Ritis K et al. (2004) Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Invest 34, 690-700.
25. Hsu HC, Lee YM, Tsai WH et al. (2002) Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome. Oncology 63, 64-9.
26. Sakane T, Takeno M, Suzuki N et al. (1999) Behcet's disease. N Engl J Med 341, 1284-91.
27. Raza A, Candoni A, Khan U et al. (2004) Remicade as TNF suppressor in patients with myelodysplastic syndromes. Leuk Lymphoma 45, 2099-104.
28. Lehner TH (1999) Immunopathogenesis of Behcet's disease. Ann Med Interne 150, 483-7.
29. Dantal J, Soulillou JP (2005) Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med 352, 1371.